The feature set II (FSII) adds four more variables to the FSI, namely tumor diameter > 5 cm, peritoneal washing status, ER status and CD171 expression (L1CAM, postoperative L1 cell-adhesion molecule expression status). Here, ESR1 is linked to neoplasm.